These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2838557)

  • 1. [Killer T cell activity specific to Epstein-Barr virus in patients with uterine cervical cancer].
    Kitano Y; Fujisaki S; Okamura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):647-8. PubMed ID: 2838557
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological disorder against the Epstein-Barr virus infection and prognosis in patients with cervical carcinoma.
    Kitano Y; Fujisaki S; Nakamura N; Miyazaki K; Katsuki T; Okamura H
    Gynecol Oncol; 1995 May; 57(2):150-7. PubMed ID: 7537239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
    AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
    Felton SC; Hoffmann CC; Kreier JP; Glaser R
    Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
    Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
    J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Herpesvirus hominis type 2 and Epstein-Barr virus antibodies in patients with cancer of the uterine cervix].
    Vestergaard BF; Hornsleth A; Pedersen SN
    Ugeskr Laeger; 1973 Jul; 135(27):1425-8. PubMed ID: 4357007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic Epstein-Barr virus infection].
    Imashuku S; Teramura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer lymphocyte function in cervical cancer patients.
    Pulay TA; Benczur M; Varga M
    Neoplasma; 1982; 29(2):237-40. PubMed ID: 7110449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cellular immune response to EBV by using cloned T cell lines.
    Slovin SF; Schooley RT; Thorley-Lawson DA
    J Immunol; 1983 May; 130(5):2127-32. PubMed ID: 6187840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of HPV Infection.
    Garcia-Chacon R; Velasco-Ramirez SF; Flores-Romo L; Daneri-Navarro A
    Arch Med Res; 2009 Aug; 40(6):443-8. PubMed ID: 19853184
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].
    Konno M
    Hokkaido Igaku Zasshi; 1989 Mar; 64(2):125-38. PubMed ID: 2543617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
    Kaplan J; Shope TC
    Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of the Epstein-Barr virus-host relationship in AIDS-related complex patients.
    Ragona G; Sirianni MC
    Cancer Detect Prev Suppl; 1987; 1():549-52. PubMed ID: 2826004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients].
    Mu M
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.